Reaction
Detachment Of Retinal Pigment Epithelium reporting signals
As of the last recalculation, Detachment Of Retinal Pigment Epithelium appears in 860 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 443.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 311 | 443.6 | 448.9 |
| Aflibercept | 148 | 138.5 | 139.1 |
| Faricimab | 31 | 96.0 | 96.4 |
| Encorafenib | 22 | 55.2 | 55.3 |
| Bevacizumab | 171 | 41.5 | 41.5 |
| Trametinib | 35 | 36.5 | 36.6 |
| Dabrafenib | 23 | 27.1 | 27.1 |
| Moxifloxacin Hydrochloride | 16 | 19.4 | 19.5 |
| Vemurafenib | 7 | 14.2 | 14.2 |
| Travoprost | 4 | 11.2 | 11.2 |